News
Novavax Inc. (NASDAQ:NVAX) is one of the best cheap stocks with huge upside potential. On June 11, BTIG maintained a Buy ...
Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated ...
Novavax Inc. closed 60.86% short of its 52-week high of $17.81, which the company reached on July 26th.
He stated that the episode of the last six months showed just how brutally efficient the price discovery process is, in any ...
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
2h
Zacks Investment Research on MSNNovavax (NVAX) Rises Higher Than Market: Key FactsNovavax (NVAX) closed the most recent trading day at $6.97, moving +1.9% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.14%. On the other hand, the ...
Get the latest Novavax, Inc. (NVAX) stock news and headlines to help you in your trading and investing decisions.
Novavax Inc. (NASDAQ:NVAX) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 17, Citi initiated coverage of Novavax Inc.
Novavax Inc. closed 61.59% short of its 52-week high of $17.81, which the company achieved on July 26th.
Novavax, Inc. (Nasdaq: NVAX) today announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV ...
Novavax (NVAX) stock dropped after Citi issued a Sell rating, citing concerns over its respiratory vaccine-focused pipeline. Read more here.
Analysts at Citigroup initiated coverage on shares of Novavax (NASDAQ:NVAX – Get Free Report) in a note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set a “sell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results